New osteoporosis therapy's dual effects on bone tissue
Sclerostin is a protein produced by osteocytes in the bone that inhibits bone formation. A recent analysis of results from a clinical trial reveals the beneficial effects of romosozumab, an antibody therapy that targets sclerostin, ...
Jun 25, 2019
0
4